

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home Sirius Therapeutics Files for Hong Kong IPO with Lead siRNA Candidate SRSD107 in Phase II

Sirius Therapeutics Files for Hong Kong IPO with Lead siRNA Candidate SRSD107 in Phase II

CST Updated Apr 01, 2026 00:35

Share:

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.